{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:49:22Z","timestamp":1761490162613},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,24]]},"DOI":"10.18632\/oncotarget.13968","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T14:19:58Z","timestamp":1482157198000},"page":"5703-5716","source":"Crossref","is-referenced-by-count":5,"title":["Immunotherapy for patients with advanced pancreatic carcinoma: a promising treatment"],"prefix":"10.18632","volume":"8","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhao","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouyang","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huizhou Municipal Central Hospital, Huizhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoning","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufang","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokai","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"School of medicine, South China University of Technology, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusheng","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoliang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"},{"name":"Graduate College, Southern Medical University, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhong","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuixing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong General Hospital\/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/j.gastro.2013.01.020","article-title":"Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer","volume":"144","author":"Novelli","year":"2013","journal-title":"Gastroenterology"},{"key":"2","doi-asserted-by":"crossref","first-page":"e1112942","DOI":"10.1080\/2162402X.2015.1112942","article-title":"Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?","volume":"5","author":"Marabelle","year":"2016","journal-title":"Oncoimmunology"},{"issue":"Suppl 7","key":"3","first-page":"i33","article-title":"Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Rougier","year":"2012","journal-title":"Ann Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00262-015-1679-3","article-title":"Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma","volume":"64","author":"Aguilar-Cordova","year":"2015","journal-title":"Cancer Immunol Immunother"},{"issue":"Suppl 7","key":"5","first-page":"i33","article-title":"Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Rougier","year":"2012","journal-title":"Ann Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/CJI.0000000000000012","article-title":"A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer","volume":"37","author":"Oka","year":"2014","journal-title":"J Immunother"},{"key":"7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CJI.0000000000000020","article-title":"Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer","volume":"37","author":"Yanagisawa","year":"2014","journal-title":"J Immunother"},{"key":"8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00262-014-1566-3","article-title":"Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer","volume":"63","author":"Song","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/MPA.0b013e3182965dde","article-title":"Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer","volume":"42","author":"Xu","year":"2013","journal-title":"Pancreas"},{"key":"10","first-page":"379","article-title":"Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes","volume":"28","author":"Oka","year":"2008","journal-title":"Anticancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/annonc\/mdu205","article-title":"A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer","volume":"25","author":"Leone","year":"2014","journal-title":"Ann Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00002371-199112000-00006","article-title":"Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: A summary of the Southwest Oncology Group experience","volume":"10","author":"Behrens","year":"1991","journal-title":"J Immunother"},{"key":"13","first-page":"874","article-title":"Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer","volume":"13","author":"Oka","year":"2005","journal-title":"Oncol Rep"},{"key":"14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/or.2013.2556","article-title":"A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients","volume":"30","author":"Sasada","year":"2013","journal-title":"Oncol Rep"},{"key":"15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3892\/ijo.2014.2496","article-title":"Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients","volume":"45","author":"Liljefors","year":"2014","journal-title":"Int J Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CJI.0000000000000020","article-title":"Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer","volume":"37","author":"Yanagisawa","year":"2014","journal-title":"J Immunother"},{"key":"17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1349-7006.2009.01416.x","article-title":"Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer","volume":"101","author":"Yamaue","year":"2010","journal-title":"Cancer Sci"},{"key":"18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1479-5876-11-291","article-title":"Phase I\/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer","volume":"11","author":"Yamaue","year":"2013","journal-title":"J Transl Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1615\/CritRevImmunol.v30.i4.30","article-title":"Tumor antigen presentation by dendritic cells","volume":"30","author":"Hermans","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1479-5876-12-175","article-title":"Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer","volume":"12","author":"Hinoda","year":"2014","journal-title":"J Transl Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/MPA.0b013e318197a9e3","article-title":"A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer","volume":"38","author":"Niwa","year":"2009","journal-title":"Pancreas"},{"key":"22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MPA.0b013e31822398c6","article-title":"Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and\/or S-1 in patients with advanced pancreatic carcinoma","volume":"41","author":"Okamoto","year":"2012","journal-title":"Pancreas"},{"key":"23","first-page":"24","article-title":"Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer","volume":"25","author":"Egawa","year":"2005","journal-title":"Anticancer Res"},{"key":"24","first-page":"831","article-title":"Long-term outcome of immunotherapy for patients with refractory pancreatic cancer","volume":"29","author":"Morisaki","year":"2009","journal-title":"Anticancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Lefebvre","year":"1994","journal-title":"BMJ"},{"key":"26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Laird","year":"1986","journal-title":"Control Clin Trials"},{"key":"27","article-title":"Cancer recurrence following Immune-Suppressive therapies in patients with Immune-Mediated diseases: A systematic review and meta-analysis","author":"Ananthakrishnan","year":"2016","journal-title":"Gastroenterology"},{"key":"28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/annonc\/mdl463","article-title":"Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: A multicenter phase II trial","volume":"18","author":"Depenbrock","year":"2007","journal-title":"Ann Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1200\/JCO.2007.11.8521","article-title":"Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer","volume":"25","author":"Fuchs","year":"2007","journal-title":"J Clin Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10637-009-9265-1","article-title":"Pilot study of irinotecan\/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer","volume":"28","author":"Kang","year":"2010","journal-title":"Invest New Drugs"},{"key":"31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1634\/theoncologist.2010-0152","article-title":"A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)","volume":"15","author":"Goldberg","year":"2010","journal-title":"Oncologist"},{"key":"32","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/bjc.2013.408","article-title":"A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer","volume":"109","author":"Chen","year":"2013","journal-title":"Br J Cancer"},{"key":"33","first-page":"3321","article-title":"Immuno-cell therapy of cancer in Japan","volume":"24","author":"Egawa","year":"2004","journal-title":"Anticancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3390\/ijms15034104","article-title":"Influence of interferon-alpha combined with chemo (radio) therapy on immunological parameters in pancreatic adenocarcinoma","volume":"15","author":"Bazhin","year":"2014","journal-title":"Int J Mol Sci"},{"key":"35","doi-asserted-by":"crossref","first-page":"e26662","DOI":"10.4161\/onci.26662","article-title":"Vaccine therapy for pancreatic cancer","volume":"2","author":"Zheng","year":"2013","journal-title":"Oncoimmunology"},{"key":"36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.cji.0000164038.41104.f5","article-title":"Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells","volume":"28","author":"Eigler","year":"2005","journal-title":"J Immunother"},{"key":"37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gut.2006.108621","article-title":"Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model","volume":"56","author":"Dauer","year":"2007","journal-title":"Gut"},{"key":"38","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.2005.06.023","article-title":"Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial","volume":"23","author":"de_Gramont","year":"2005","journal-title":"J Clin Oncol"},{"key":"39","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1200\/JCO.2009.25.7550","article-title":"Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205","volume":"28","author":"Fenoglio-Preiser","year":"2010","journal-title":"J Clin Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1200\/JCO.2012.43.3680","article-title":"Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study","volume":"31","author":"Kitano","year":"2013","journal-title":"J Clin Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.2002.11.149","article-title":"Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297","volume":"20","author":"Benson","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:59:58Z","timestamp":1596722398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1,24]]}},"alternative-id":["13968","27992378"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13968","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}